GSK launches $50 million venture capital fund to invest in pioneering bioelectronic medicines and technologies

'Action Potential Venture Capital' makes first investment in SetPoint Medical, developer of implantable device for treating inflammatory diseases.
Source: GSK news - Category: Pharmaceuticals Source Type: news